DNA chips: the future of biomarkers.
DNA chips are small, solid supports such as microscope slides onto which thousands of cDNAs or oligonucleotides are arrayed, representing known genes or simply EST clones, or covering the entire sequence of a gene with all its possible mutations. Fluorescently labeled DNA or RNA extracted from tissues is hybridized to the array. Laser scanning of the chip permits quantitative evaluation of each individual complementary sequence present in the sample. DNA chip technology is currently being proposed for qualitative and quantitative applications, firstly for the detection of point mutations, small deletions and insertions in genes involved in human diseases or affected during cancer progression; secondly, to determine on a genome-wide basis the pattern of gene expression in tumors, as well as in a number of experimental situations. The extraordinary power of DNA chips will have a strong impact on medicine in the near future, both in the molecular characterization of tumors and genetic diseases and in drug discovery and evaluation. Quantitative applications will soon spread through all fields of biology.
De Benedetti
V M
VM
Institute for Cancer Research and Treatment, Candiolo, Turin.
Biglia
N
N
Sismondi
P
P
De Bortoli
M
M
D015415:Biomarkers; D030342:Genetic Diseases, Inborn / Q000235:genetics; D005819:Genetic Markers; D005821:Genetic Techniques; D006801:Humans; D009154:Mutation; D020411:Oligonucleotide Array Sequence Analysis
D015415:Biomarkers; D005819:Genetic Markers